MARKET

ARGX

ARGX

Argenx
NASDAQ

Real-time Quotes | Nasdaq Last Sale

125.37
-1.02
-0.81%
After Hours: 125.37 0 0.00% 16:24 09/20 EDT
OPEN
124.93
PREV CLOSE
126.39
HIGH
125.80
LOW
124.15
VOLUME
134.52K
TURNOVER
--
52 WEEK HIGH
150.92
52 WEEK LOW
63.81
MARKET CAP
4.78B
P/E (TTM)
-43.2474
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ARGX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ARGX News

  • Ascendis Pharma Perhaps Not Best Of 76 Compared Biotechs
  • Seeking Alpha - Article.09/12 12:01
  • argenx to Present at Morgan Stanley 17th Annual Global Healthcare Conference
  • GlobeNewswire.09/03 06:00
  • Is argenx SE's (EBR:ARGX) CEO Paid Enough Relative To Peers?
  • Simply Wall St..08/07 09:43
  • Morgan Stanley Maintains Overweight on argenx, Raises Price Target to $173
  • Benzinga.08/06 13:19

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About ARGX

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.
More

Webull offers argenx SE - ADR (ARGX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.